News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
193 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Deals
Aviragen Therapeutics and Vaxart Enter into Merger Agreement
The merger will result in a combined company, Vaxart, focused on developing orally-delivered therapeutics and prophylactics to address a variety of viral infections.
October 30, 2017
·
11 min read
BioCanCell Announces Exploration of Funding Round Conditioned on a Going Private Transaction and Business Development Update
The investors have informed BioCanCell that the execution of the Private Investment is dependent on BioCanCell’s becoming a private company.
October 30, 2017
·
4 min read
Trading of Össur Shares to be Concentrated on Nasdaq Copenhagen From 6 December 2017
By concentrating the trading on one market, trading liquidity of Össur shares will increase and the price formation will be more effective for the benefit of all shareholders.
October 30, 2017
·
2 min read
Drug Development
MediciNova Announces the Presentation of Additional Positive Top-Line Results from the SPRINT-MS Phase IIb Trial of MN-166 (ibudilast) in Progressive MS
The drug achieved a statistically significant 48% reduction in whole brain atrophy with a favorable safety and tolerability profile.
October 30, 2017
·
10 min read
Business
Iradimed Corporation Announces Third Quarter 2017 Financial Results
For the third quarter ended September 30, 2017, the Company reported revenue of $5.7 million compared to $7.7 million for the third quarter 2016.
October 30, 2017
·
15 min read
Drug Development
Kura Oncology Development Candidate KO-539 Shows Robust Preclinical Anti-Tumor Activity in NPM1- and DNMT3A-Mutant AML
The results were featured in a late-breaking presentation today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Philadelphia.
October 30, 2017
·
4 min read
Drug Development
Novartis to Present First of Its Kind Evidence For Cosentyx on Potential to Maintain Mobility in Patients With AS and PsA
The new Cosentyx data will be presented at the 2017 ACR/ARHP annual meeting next month.
October 30, 2017
·
12 min read
Business
MDxhealth Enters Into Distribution Agreement With Unilabs for SelectMDx for Prostate Cancer
Under the deal,, Unilabs medical laboratory in Geneva Switzerland, will perform SelectMDx service testing for all its clinical labs in France, Portugal and more.
October 30, 2017
·
4 min read
HyperMed Imaging Announces Cardiology Group as Early Adopter For Its New HyperView Product
The HyperView is a fast, handheld, battery operated, non-invasive and portable diagnostic imaging device that is used to assess tissue oxygenation without contacting the patient and without the need for injectable contrast.
October 30, 2017
·
3 min read
Deals
Ablynx Closes $200M IPO in the United States
The net proceeds are estimated at $182.3 million.
October 30, 2017
·
7 min read
Previous
13 of 20
Next